Welcome to Lab Test Consult

You can log in and post your comments

Share your knowledge and experience!

Member Login
Lost your password?

Diagnostics for viruses a step closer to reality

February 16, 2012
By

Contact: Jo Kelly
jo@campuspr.co.uk
44-113-357-2103
University of Leeds

 

Scientists have developed a technique which could form the basis of a non-invasive diagnostic for Adenovirus the virus responsible for a large number of common illnesses.

The biosensor technology developed by researchers at the University of Leeds can not only detect the presence of the virus, it can also identify the individual strain and the number of virus particles present.

The study underpinning this research is published today (15 February) in the journal Biosensors Bioelectronics.

Currently, testing for viruses is complicated, time consuming and requires specialist preparation of samples to identify virus DNA. Using this new technique, testing for viruses could be much quicker, simpler and ultimately less costly. For patients, this sort of diagnostic would mean faster treatment.

“This is a significant leap forward in testing for viruses,” says Professor Paul Millner of the University’s Faculty of Biological Sciences, who supervised the study. “For the first time we’ve been able to test for the presence of a whole virus, rather than having to seek out its genetic material, and the first time the number of virus particles has been counted using a lab-on-a-chip device. These are both exciting developments.”

Adenovirus is a common virus found in vertebrates and causes many illnesses, from the common cold through to gastroenteritis. People with strong immune systems are not badly affected by the virus, but for those with a compromised or immature immune system – such as small children or HIV sufferers it can have fatal consequences.

The new technique uses antibodies attached to an electrical sensor. By measuring the sensor’s electrical changes, researchers were able to identify how many virus particles were present, and determine the type of virus dependent on its response.

“There’s a long way to go before the technology might reach a doctor’s surgery, but we’ve proven the concept,” says Rebecca Caygill, the PhD student behind the study. “We now need to increase the sensitivity of the test and optimise the different stages of the process so that we can consider scaling it up for clinical trials.”

The research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and ELISHA Systems Ltd, the company commercialising this adenovirus biosensor and other biosensors for healthcare applications.

 

 


Article source: http://www.eurekalert.org/pub_releases/2012-02/uol-dfv021312.php

Share

Related posts:

  1. Molecular Diagnostics
  2. "Extractinator" Could Bring High-Tech Medical Diagnostics to Rural Areas
  3. Pinpoint MD nears $1.5 million for digital diagnostics platform
  4. Aria Diagnostics Emerges From Stealth With New Blood-Based Prenatal Test
  5. Medical records closer to being shared by doctors across state
  6. China Health Labs & Diagnostics Ltd. announces $10.1 million sales order for its food safety business
  7. Atherotech Diagnostics Lab Adds New CFO and VP of Human Resources
  8. Frost & Sullivan Commends Biodesix for Raising the Bar in Personalized Medicine Diagnostics With the VeriStrat(R) Test
  9. Idaho Tech Demos Clinical Utility of FilmArray Respiratory Dx; Plans to Add Blood, GI Panels

Tags:



New post

Posts

November 2017
M T W T F S S
« Aug    
 12345
6789101112
13141516171819
20212223242526
27282930  

Posts

Recent comments

    Contact Sign In

    Email Marketing You Can Trust